Abstract

http://ssrn.com/abstract=1431180
 
 

Citations (1)



 


 



The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices


Thomas Pogge


Yale MacMillan Center; Centre for Applied Philosophy and Public Ethics; Centre for the Study of Mind in Nature

July 7, 2009

INCENTIVES FOR GLOBAL PUBLIC HEALTH: PATENT LAW AND ACCESS TO MEDICINES, Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (eds.), Cambridge: Cambridge University Press, 2010

Abstract:     
Thomas Pogge contends that pricing advanced medicines beyond the reach of the poor and encouraging neglect of diseases concentrated among them, the TRIPS Agreement is responsible for avoidable death and disease on a massive scale. Pharmaceutical patents as globalised through the TRIPS Agreement cannot be defended by appeal to natural rights. Nor can they be justified in terms of mutual benefit or usefulness, because the global poor are deprived of their freedom to buy medicines at competitive prices yet often cannot benefit from the enhanced arsenal of advanced medicines. One way of mitigating the injustice involves creation of the Health Impact Fund (HIF), an international agency that would provide a standing option to register any new medicine for health impact rewards. By registering, a firm would agree to sell its product globally at a price fixed by the HIF at the lowest feasible cost of production and distribution. In exchange, the firm would receive for a fixed time payments based on this product’s assessed global health impact. If adequately funded, the HIF would serve as a complement to the patent regime by alleviating its deficiencies. In particular, the HIF would generate a stream of pharmaceutical innovations that would be cheaply available to all and would end the systemic research neglect of diseases concentrated among the poor.

Number of Pages in PDF File: 26

Keywords: The Health Impact Fund, Patent Law, Access to Essential Medicines, the TRIPS Agreement, Philosophy, Justice

JEL Classification: 034, I11

Accepted Paper Series





Download This Paper

Date posted: July 9, 2009  

Suggested Citation

Pogge, Thomas, The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices (July 7, 2009). INCENTIVES FOR GLOBAL PUBLIC HEALTH: PATENT LAW AND ACCESS TO MEDICINES, Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (eds.), Cambridge: Cambridge University Press, 2010. Available at SSRN: http://ssrn.com/abstract=1431180

Contact Information

Thomas Pogge (Contact Author)
Yale MacMillan Center ( email )
P.O. Box 208206
New Haven, CT 06520-8206
United States
203-4322272 (Phone)
HOME PAGE: http://pantheon.yale.edu/~tp4/index.html
Centre for Applied Philosophy and Public Ethics
Canberra, Australian Capital Territory 2601
Australia
02-61255485 (Phone)
Centre for the Study of Mind in Nature
PO Box 6706 St Olavs plass
Oslo, N-0317
Norway
Feedback to SSRN


Paper statistics
Abstract Views: 2,141
Downloads: 565
Download Rank: 26,629
Citations:  1

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo5 in 0.375 seconds